Follow us:Follow Us on Twitter Like Us on Facebook Follow Us on Google+ Watch videos on our Youtube channel
Cedars-Sinai Heart Institute is currently conducting the following Aortic trials:
Single Center Investigator-Initiated Investigational Device Exemption: Feasibility of Endovascular Repair of Ascending Aortic Pathologies using Medtronic Valiant Stent Graft System
National Principal Investigator: Ali Khoynezhad, MD
IRB Approval Number: 20766-01
Contact: Anila Saeed: 424-315-4431
This is the first FRA-approved study in the United States to treat various ascending aortic pathologies using a less-invasive stent graft technology. The goal of the study is to document the safety of the stent grafting in the ascending thoracic aorta. The patients are followed up to five years.